Overexpression of CASP1 triggers acute promyelocytic leukemia cell pyroptosis and differentiation

Eur J Pharmacol. 2023 Apr 15:945:175614. doi: 10.1016/j.ejphar.2023.175614. Epub 2023 Feb 22.

Abstract

Caspase-1 (CASP1)-mediated classical pyroptosis plays a key role in cancer development and management, however, the role of CASP1 and its regulation has not yet been documented for acute promyelocytic leukemia (APL). Here, we found that CASP1/GSDMD had lower expression in patients with APL and most other subtypes of primary de novo acute myeloid leukemia (AML) and was increased in all-trans-retinoic acid (ATRA)-treated APL cells. We showed that ATRA increases and activates CASP1 to trigger the pyroptosis and differentiation of APL cells. Mechanistically, ATRA could induce CASP1 expression via the IFNγ/STAT1 pathway in APL cells. In conclusion, ATRA-induced activation of CASP1 may serve as a suppressor in APL progression, as it triggers pyroptotic cell death and differentiation.

Keywords: ATRA; Acute promyelocytic leukemia; CASP1; Differentiation; GSDMD; Pyroptosis.

MeSH terms

  • Caspase 1
  • Cell Differentiation
  • Humans
  • Leukemia, Promyelocytic, Acute* / genetics
  • Pyroptosis
  • Tretinoin / pharmacology

Substances

  • Caspase 1
  • Tretinoin